摘要:
It is intended to provide a method of rapid methylation of an aromatic compound or an alkenyl compound, which is capable of obtaining an aromatic compound or an alkenyl compound labeled with a methyl group or a fluoromethyl group under a mild condition rapidly in high yield using an organic boron compound whose toxicity is not so high as a substrate; a kit for preparing a PET tracer to be used in the same, and a method of producing a PET tracer using the same. In an aprotic polar solvent, methyl iodide or X-CH2F (wherein X is a functional group which can be easily released as an anion), an organic boron compound in which an aromatic ring or an alkenyl group is attached to boron are subjected to cross-coupling in the presence of a palladium(0) complex, a phosphine ligand, and a base.
摘要:
It is intended to provide a method of rapid methylation of an aromatic compound or an alkenyl compound, which is capable of obtaining an aromatic compound or an alkenyl compound labeled with a methyl group or a fluoromethyl group under a mild condition rapidly in high yield using an organic boron compound whose toxicity is not so high as a substrate; a kit for preparing a PET tracer to be used in the same, and a method of producing a PET tracer using the same. In an aprotic polar solvent, methyl iodide or X-CH2F (wherein X is a functional group which can be easily released as an anion), an organic boron compound in which an aromatic ring or an alkenyl group is attached to boron are subjected to cross-coupling in the presence of a palladium(0) complex, a phosphine ligand, and a base.
摘要:
The present invention relates to a method for assessing mitochondrial function in a tissue or organ other than the kidney in a test subject, including: a step of calculating a ratio (BUN/CRE) of blood urea nitrogen (BUN) concentration to blood creatinine (CRE) concentration in a test subject; and a step of estimating mitochondrial activity in a tissue or organ other than the kidney in the test subject using the calculated ratio (BUN/CRE).
摘要:
Provided is a compound represented by formula (1-0):
wherein in formula (1-0), R represents -O(CH 2 ) n -, -O(CH 2 ) n OC 2 H 4 -, -CH 2 O(CH 2 ) n - or -CH 2 O(CH 2 ) n OC 2 H 4 -; n represents an integer from 1 to 5; and Q 1 represents F or -OCH 3 .
摘要:
The present invention provides a diagnostic agent for a therapeutic effect on cancer, containing a compound represented by formula (1-0).
(In formula (1-0), R represents -O(CH 2 ) n -, -O(CH 2 ) n OC 2 H 4 -, -CH 2 O(CH 2 ) n -, or -CH 2 O(CH 2 ) n OC 2 H 4 -, n represents an integer of 1 to 5, and Q 1 represents F or -OCH 3 .)